Oral E. coli Vaccine Promising
The August 2000 issue of the journal Infection and Immunity published findings that seem promising for an experimental oral vaccine against pathogenic Escherichia coli. Currently being tested on Israeli military volunteers, the vaccine appears to be safe and to stimulate an appropriate immune response. The study was conducted by researchers from the Israeli Defense Force; Tel Aviv University; Technion-Israel Institute of Technology; University of Negrev; Hebrew University and Hassadah Medical School, Jerusalem; the Walter Reed Army Institute of Research, Washington, DC; and the University of Goteborg, Sweden. For more information visit www.asm.usa.org.
CDC Strategies Preventing Hospital-Onset C difficile Effectiveness Inconclusive in Testing
April 15th 2024Hospitals using CDC prevention strategies had different incidences of hospital-associated Clostridioides difficile infection compared to those that didn't, but the reasons are not necessarily the strategies themselves.
